Literature DB >> 23531794

Complex histopathologic response in rat kidney to oral β-myrcene: an unusual dose-related nephrosis and low-dose alpha2u-globulin nephropathy.

Mark F Cesta1, Gordon C Hard, John T Boyce, Michael J Ryan, Po C Chan, Robert C Sills.   

Abstract

Oral gavage studies with β-myrcene in male F344 rats showed a complex renal pathology comprising both alpha2u-globulin (α2u-g) nephropathy, an unusual nephrosis involving the outer stripe of outer medulla (OSOM), and an increased incidence of renal tubule tumors by 2 years. In the 90-day and 2-year studies, respectively, α2u-g nephropathy and linear papillary mineralization were observed in males at the two lower doses but were absent from the high dose. Nephrosis was characterized by dilation of the S3 tubules, nuclear enlargement (including karyomegaly), and luminal pyknotic cells, all in the outermost OSOM. Nephrosis was minimal at the higher doses in the 90-day study, but progressed to a severe grade in males dosed with 1,000 mg/kg for 2 years. Renal tubule tumors developed in treated groups with incidences up to 30% in the 250 and 500 mg/kg male dose groups. Tumors at the lower doses in males may have been associated with α2u-g nephropathy, while those at higher doses in both sexes may have been due to the nephrosis. Because β-myrcene induced a complex spectrum of renal pathology, the α2u-g nephropathy mechanism cannot be the sole mechanism of carcinogenesis in these rats.

Entities:  

Keywords:  alpha2u-globulin; kidney; nephropathy; rat.; β-myrcene

Mesh:

Substances:

Year:  2013        PMID: 23531794     DOI: 10.1177/0192623313482057

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  3 in total

1.  Proceedings of the 2021 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Shambhunath Choudhary; Gregory A Krane; Quinci Plumlee; Erin M Quist; Andrew W Suttie; Debra A Tokarz; Jerrold M Ward; Michelle Cora
Journal:  Toxicol Pathol       Date:  2021-10-11       Impact factor: 1.902

2.  Neuroprotective effects of β-myrcene following global cerebral ischemia/reperfusion-mediated oxidative and neuronal damage in a C57BL/J6 mouse.

Authors:  Osman Ciftci; M Namik Oztanir; Aslı Cetin
Journal:  Neurochem Res       Date:  2014-06-28       Impact factor: 3.996

Review 3.  Myrcene-What Are the Potential Health Benefits of This Flavouring and Aroma Agent?

Authors:  Shelini Surendran; Fatimah Qassadi; Geyan Surendran; Dash Lilley; Michael Heinrich
Journal:  Front Nutr       Date:  2021-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.